Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
Stanford University · NCT04109846
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–55 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 300
- US sites recruiting
- 1
- Study start
- April 11, 2019
- Record last updated
- April 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.
Being studied: Non-euploid embryo transfer; Euploid Transfer
Conditions: Aneuploidy; Mosaicism; Pregnancy Outcome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Available aneuploid or mosaic embryos
- No other acceptable embryos available
- Willing to travel to Stanford for treatment
- English language fluency
Exclusion Criteria
- Use of international donor eggs or sperm not tested according to FDA guidelines.
- Living outside the United States
- Embryos with Triploidy are not eligible for transfer in this protocol
Recruiting US locations
Stanford Fertility and Reproductive Medicine Center
Sunnyvale, CA 94087
Site contact: Ronit Mazzoni, MS · 408-688-9749 · rmazzoni@stanfordchildrens.org
Study contacts (from the official record)
- Ronit Mazzoni, MS · 408-688-9892 · rmazzoni@stanford.edu
- REI Research Coordinator · 408-688-9892 · rei-research@lists.stanford.edu
Similar studies in California
All pregnancy studies in California →- RecruitingHealthy volunteersPhase 1/Phase 2
Hyperemesis Gravidarum Risk Reduction With Metformin
University of Southern California
- Location
- Los Angeles, CA
- Eligibility basics
- Ages 18–49 · Women only
- RecruitingHealthy volunteers
Scaling Effective Behavioral Interventions With MPC Avatar-Based Virtual Training
dfusion Inc
- Location
- Scotts Valley, CA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- Los Angeles, CA + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteers
A Study to Assess Deucravacitinib Safety in Pregnancy
Bristol-Myers Squibb
- Location
- La Jolla, CA
- Eligibility basics
- Any age listed · Women only